IP Library Granted Patent US 10,525,171
Granted Patent B2
US 10,525,171 · App. 14/162,900 · Granted Jan 7, 2020

Coatings for medical devices

Inventors: Patrick Ruane (Redwood City, CA); Cameron Wilson (Moss Beach, CA); Steven Ummel (Menlo Park, CA); Arlene Alcantara (San Jose, CA); Jackie Joe Hancock (Cork, IE); Qi Zhan (Antioch, CA)
Assignee: THE SPECTRANETICS CORPORATION
A61L29/16A61L29/085A61M25/10C08L71/02A61L2300/106A61L2300/416A61L2420/06A61M25/1002A61M2025/105A61M2025/1075
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,525,171
App. No.
14/162,900
Granted
Jan 7, 2020
Kind
B2
Abstract

A method and device for local delivery of a water-insoluble therapeutic agent to the tissue of a normal or diseased body lumen is disclosed. An expandable structure of a medical disposable device, such as a balloon of a balloon catheter, is coated with a non-durable coating which includes an amphiphilic polymer or copolymer, in embodiments polyethylene glycol, having a substantially water-insoluble therapeutic agent dispersed therein. In some embodiments, the coating may also include iodine. The medical disposable device is inserted into a body lumen, and expanded to contact the non-durable coating against the body lumen and deliver the substantially water-insoluble therapeutic agent to the body lumen tissue.

Claims (38)

1. A catheter assembly for insertion into the vasculature comprising:

a balloon having an outer surface; and

a coating disposed on the outer surface of the balloon, wherein the coating comprises;

an amphiphilic polymer matrix;

a therapeutic agent dispersed throughout the polymer matrix; and

iodine,

wherein a ratio of the amphiphilic polymer matrix to the therapeutic agent to the iodine is about 50:45:5 to about 70:25:5,

wherein the coating has a thickness from about 0.01 μm to about 10 μm and a therapeutic agent density of from about 0.1 μg/mm 2 to about 1.5 μg/mm 2 .

2. The catheter assembly of claim 1 , wherein the polymer matrix comprises a polymer selected from the group consisting of polyethylene glycol, polyvinyl pyrrolidone and hydroxypropyl cellulose.

3. The catheter assembly of claim 1 , wherein the therapeutic agent is paclitaxel.

4. The catheter assembly of claim 1 , wherein the polymer matrix comprises polyethylene glycol.

5. The catheter assembly of claim 4 , wherein the polyethylene glycol has a molecular weight of 1.5 KD to 50 KD.

6. The catheter assembly of claim 1 , wherein the coating has a therapeutic agent density of from about 0.25 μg/mm 2 to about 0.8 μg/mm 2 .

7. A catheter assembly for insertion into the vasculature comprising:

a balloon having an outer surface;

an amphiphilic coating comprising:

a polymer matrix complexed with iodine disposed on the outer surface of the balloon; and

a therapeutic agent dispersed in the matrix complexed with the iodine,

wherein a ratio of the polymer matrix to the therapeutic agent to the iodine is about 50:45:5 to about 70:25:5,

wherein the amphiphilic coating has a thickness from about 0.01 μm to about 10 μm and a therapeutic agent density of from about 0.1 μg/mm 2 to about 1.5 μg/mm 2 .

8. The catheter assembly of claim 7 , wherein the iodine is complexed with polyethylene glycol, polyvinyl pyrrolidone, or hydroxypropyl cellulose.

9. The catheter assembly of claim 7 , wherein the therapeutic agent is paclitaxel.

10. The catheter assembly of claim 7 , wherein the polymer matrix comprises polyethylene glycol.

11. The catheter assembly of claim 10 , wherein the polyethylene glycol has a molecular weight of 1.5 KD to 50 KD.

12. The catheter assembly of claim 7 , wherein the coating has a therapeutic agent density of from about 0.25 μg/mm 2 to about 0.8 μg/mm 2 .

13. A catheter assembly for insertion into the vasculature comprising:

a balloon having an outer surface;

an amphiphilic coating disposed on the outer surface of the balloon, the amphiphilic coating comprising:

polyethylene glycol

a therapeutic agent comprising paclitaxel dispersed throughout the polyethylene glycol; and

iodine,

wherein a ratio of the polymer matrix to the therapeutic to the iodine is about 50:45:5 to about 70:25:5,

wherein the amphiphilic coating has a therapeutic agent density of from about 0.1 μg/mm 2 to about 1.5 μg/mm 2 , and

wherein the amphiphilic coating has a thickness from about 0.01 μm to about 10 μm.

14. The catheter assembly of claim 1 , wherein the polymer matrix comprises at least one amphiphilic polymer.

15. The catheter assembly of claim 1 , wherein the polymer matrix comprises at least one amphiphilic copolymer.

16. The catheter assembly of claim 7 , wherein the polymer matrix comprises at least one amphiphilic polymer.

17. The catheter assembly of claim 7 , wherein the polymer matrix comprises at least one amphiphilic copolymer.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Aug 10, 2017
From: MIDCAP FINANCIAL TRUST
To: THE SPECTRANETICS CORPORATION; ANGIOSCORE INC.
Reel/Frame 043518/0142 →
RELEASE OF SECURITY INTEREST Recorded Aug 10, 2017
From: MIDCAP FINANCIAL TRUST
To: THE SPECTRANETICS CORPORATION; ANGIOSCORE INC.
Reel/Frame 043518/0066 →
SECURITY INTEREST (TERM) Recorded Dec 11, 2015
From: THE SPECTRANETICS CORPORATION
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 037269/0506 →
SECURITY INTEREST (REVOLVER) Recorded Dec 11, 2015
From: THE SPECTRANETICS CORPORATION
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 037269/0425 →
SECURITY INTEREST Recorded Jul 2, 2015
From: THE SPECTRANETICS CORPORATION
To: WELLS FARGO BANK, NATIONAL ASSOCIATION
Reel/Frame 036055/0156 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2015
From: COVIDIEN LP
To: THE SPECTRANETICS CORPORATION
Reel/Frame 035074/0106 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 27, 2014
From: RUANE, PATRICK; WILSON, CAMERON; UMMEL, STEVEN; ALCANTARA, ARLENE; HANCOCK, JACKIE JOE; ZHAN, QI
To: COVIDIEN LP
Reel/Frame 032965/0537 →
Continuity (1)
Related Publication 20150209555A1 · Jul 30, 2015